soft bring risk
miss fy top-line guide-down build worri
outlook mind reinforc uw rate
miss emerg issu bag wipe stock trade
vs reaction profit miss underli fy profit
guide-down highlight march note reiter uw slow
top-line growth drive multipl compress net highlight key
neg emerg quarter lower organ sale
growth guidanc prior quarter left year
call competit weak trash bag wipe expect
linger reduc underli ep guidanc cent
prior highlight emerg headwind
includ yoy ep drag higher tax well willing invest
increment trade promot brand support address trash bags/wip
competit issu net commend continu invest behind
busi long-term weaker result lack full price
realiz stand contrast improv hpc peer pg/cl/kmb
report solid acceler organ sale growth creat risk
still premium price-to-earnings ev/ebitda valuat
continu prefer ow-rat pg offer higher organ sale growth
organ sale growth pg vs trade turn
discount
competit pressur trash bag continu wipe emerg
wrap sale mix clorox disinfect wipe estim hsd
sale mix expect linger quarter invest
address price gap trash bag discuss previous key
competitor hefti follow fall price increas resin price
decreas versu prior level hefti invest promot make
market share gain increas trade invest behind
categori narrow widen price gap also indic may take
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
decreas versu histor hsd-dd growth flu season
less sever decreas consumpt view issu
transitori howev also note competitor increas
promot spend price gap stretch categori
indic invest trade promot go forward defend market
share expect two issu linger creat potenti risk
estim rel typic algorithm
number report ep cent
consensu mse profit miss consensu off-set
cent ep contribut profit line primarili tax vs
model organ sale growth in-lin consensu rang
come recent report top-line miss consensu
fx/lower expect contribut along higher
expect sg drove profit miss gross margin expand bp yoy
slightli better bp consensu gross profit downsid vs
consensu gross profit miss augment higher sg sale
bp consensu continu invest behind
busi slightli forecast bp yoy sale
mse bp oper profit line item net cent benefit
lower expect tax rate ad cent vs model
cent benefit incom
sale growth segment clean segment organ sale declin estim
y-o-i underpin growth off-set declin
laundri profession product clean segment sale reflect
headwind milder cold flu season total organ
sale growth drove lower sale disinfect product notabl
wipe profession product busi household segment organ
sale decreas estim volum price/mix primarili
declin bag wrap sale share declin due lower
shipment driven mainli widen price gap busi addit
distribut loss portion portfolio partial off-set gain
litter charcoal litter grew sale top difficult dd comparison
year ago period strong perform nontrack channel
renewlif sale slightli behind overal categori declin lifestyl
segment organ sale grew estim sale growth across burt
bee brita nutranext organ sale grew estim
although result msd rang exclud argentina
ep guidanc rang narrow narrow ep guidanc
rang vs prior midpoint close
prior consensu exclud cent fy benefit lower
tax rate vs prior underli ep guidanc come
ep guidanc rang continu includ cent expect ep
dilut nutranext acquisit unchang cent neg
impact tariff unchang expect sale growth
vs prior primarili milder cold flu season heighten
competit promot activ wipe categori well lower sale
bag wrap busi relat widen price gap price increas
heighten competit promot activ also note recent charcoal
track channel weak impli organ sale growth vs
prior assum prior fx headwind benefit net
acquisit mention releas line item guidanc
remain unchang gross margin expect flat unchang
benefit price increas cost save expect off-set
neg impact cost pressur foreign currenc exchang rate ii
 expect around sale unchang iii sg
sale sale unchang reflect normal
performance-bas employe incent compens cost well cost
relat nutranext acquisit expect tax rate vs
prior also indic long-term tax rate
feder statutori rate state local tax
remain uw follow ep estim unchang
lower organ sale growth off-set favor tax rate howev
ep estim decreas prior
consensu price target fall prior base
prior downwardli revis ep estim remain uw
see price-to-earnings ev/ebitda stretch
see near-term catalyst invest address price gap
glad bag clorox disinfect wipe could creat linger invest
risk
clx mute organ sale growth neg
clx mute organ sale growth neg
emerg portfolio
emerg portfolio
hpc skew low-growth product
categori high exposur us
face signific pressur brand
demand fragment competit
retail environ limit lt
top-line potenti vs peer view
ev/ebitda
price-to-earnings high consid m-hsd
lt ep growth limit strateg potenti
risk achiev price
risk includ top-line margin upsid
improv price better expect
consolid potenti cost-cut
deriv base case
profit upsid drive multipl expans top-line margin upsid bp
better expect volum bp margin upsid declin
commod cost upsid cost-cut drive multipl expans
bull case ep
lower long-term ep growth peer limit upsid forecast lt
organ top line growth bp averag margin expans expect
valuat ep deviat averag
reflect emerg competit risk portfolio
fundament weaken challeng us hpc environ drive bp us
price downsid coupl bp volum downsid market share
pressur bp margin reinvest busi multipl
compress bear case ep
exhibit bear bull commod price risk/reward driver
valu
bp
million
million except ep
product sold
net sale
chang bp
net sale
chang bp
sell administr
net sale
chang bp
total sale
chang bp
total sale
chang bp
net sale
chang bp
net sale
net earn cont op
net sale
ep continu op
asset held sale
net properti plant equip
note loan payabl
current matur lt debt
accru liabil
common stock apic
accumul comprehens loss
total liabil stockhold equiti
depreci amort
chang a/l
accru liabil
net cash discontinu oper
net cash oper
net cash invest
purchas treasuri stock
net cash financ
effect fx chang cash
net chang cash
begin cash equival
end cash equival
pt forecast organ sale growth go forward modestli
hpc peer led improv us result build market share momentum
better price realiz continu cost save support bp om expansion/yr
drive hsd ep growth appli multipl ep slight premium
pg average given acceler fundament
share vacil currenc commod volatil
